I like a few others bought shares based on recommendations by...

I like a few others bought shares based on recommendations by various analysts. During the time I have held them there have been annoucements about new contracts where they have had pissy little revenue wins and on most occasions nothing was said about the impact these wins would have on NPAT or EBITDA.

I have tried over the passed few days to get info to come up with a view on what sp would reflect fair value. Based on the comments in the half year accounts that the core business which excludes NPfIT generated 80% of the Group Revenue and then very little info on how the big anticapted boost in EBITDA in the 2nd half (supposedly double the 1st) will be earned, I am struggling to put anything together. Looking at history is also not easy as IBA seemed to be in a better state than ISF.

Does anybody have an idea? I did start this trying to determine if I should buy a few more but now believe management is living with the fairies and selling is a better option. Does the 30% drop in the sp reflect the revised outlook or more a reflection of the mismanagement and lack of transparency?

I reckon a class action may be an option.